ORLANDO, Fla. — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in ...

Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for men vs women. Treatment guidelines in PV currently recommend maintaining ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — The standard approach of maintaining hematocrit levels less than 45% in patients with polycythemia ...

Rusfertide maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 weeks in the VERIFY study. Patients switching from placebo to rusfertide showed rapid ...

ATLANTA -- Maintaining patients with polycythemia vera at hematocrit levels below 45% reduced thrombotic complications without increasing rates of other serious adverse events compared with a higher ...

Please provide your email address to receive an email when new articles are posted on . Induction therapy with twice-weekly rusfertide helped patients with polycythemia vera achieve target hematocrit ...

THE measurement of the packed red-cell volume (or hematocrit) of the venous blood has long been recognized as a useful aid in the study of blood in a large number of clinical conditions. The technic ...

Intensive care of critically ill newborn infants has increased blood sampling and exacerbated the severity of neonatal anemia. Daily phlebotomy blood losses of 4 to 5% of the total blood volume are ...

First off, let’s define hematocrit and the blood test that Jeanson failed. Blood can be broadly categorized as comprising liquid (mainly plasma) and solids (red blood cells that carry oxygen and white ...